Home / Health / AVS Pulse IVL: Revolutionizing Artery Treatment
AVS Pulse IVL: Revolutionizing Artery Treatment
5 Mar
Summary
- IVL system enhances physician ability for complex artery procedures.
- AVS Pulse IVL aims for flexible treatment options.
- Aging demographics drive demand for hardened lesion treatment.

The AVS Pulse intravascular lithotripsy (IVL) system is designed to empower physicians, enabling them to perform complex arterial procedures with greater ease and safety. This innovation is particularly impactful for treating calcified arterial lesions associated with peripheral artery disease.
Mark Toland, Chairman of AVS Pulse, highlighted that the system simplifies treatments, allowing even less experienced physicians to manage patients previously outside their capabilities. The technology aims to provide more flexible treatment options compared to existing methods.
Clinical results from the POWER PAD II pivotal trial are encouraging, supporting the system's efficacy. With a commercial strategy in place ahead of FDA approval, AVS Pulse anticipates expanding its market reach. The increasing aging population is expected to drive further demand for IVL as hardened lesions become more common.




